Cargando…

Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations

Sustained remission is an ultimate treatment goal in the management of patients with rheumatoid arthritis (RA). Historically the frequency of sustained remission was low but the frequency of achieved sustained remission is increasing over time. The last years’ clinical studies of tight control targe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ajeganova, Sofia, Huizinga, Tom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613855/ https://www.ncbi.nlm.nih.gov/pubmed/28974987 http://dx.doi.org/10.1177/1759720X17720366

Ejemplares similares

Sustained rheumatoid arthritis remission is uncommon in clinical practice
por: Prince, Femke HM, et al.
Publicado: (2012)

Low levels of PCSK9 are associated with remission in patients with rheumatoid arthritis treated with anti-TNF-α: potential underlying mechanisms
por: Frostegård, Johan, et al.
Publicado: (2021)

An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression
por: van der Helm-van Mil, Annette H. M., et al.
Publicado: (2013)

Patient’s perspective of sustained remission in rheumatoid arthritis
por: Contreras-Yáñez, Irazú, et al.
Publicado: (2017)

Prevalence and predictors for sustained remission in rheumatoid arthritis
por: Sung, Yoon-Kyoung, et al.
Publicado: (2019)

Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
por: Kimura, Noriko, et al.
Publicado: (2019)

Defining and characterizing sustained remission in patients with rheumatoid arthritis
por: Curtis, Jeffrey R., et al.
Publicado: (2017)

Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis
por: Sung, Yoon-Kyoung, et al.
Publicado: (2019)

Sustained Remission in Rheumatoid Arthritis: Time to Withdraw Treatment?
por: Sungur, Can M.
Publicado: (2021)

Ultrasound remission in patients with rheumatoid arthritis in clinical remission
por: Fakhfakh, Rym, et al.
Publicado: (2021)

Rheumatoid Arthritis: Defining Clinical and Ultrasound Deep Remission
por: Hèctor, Corominas, et al.
Publicado: (2020)

Severe Mononeuritis Multiplex due to Rheumatoid Vasculitis in Rheumatoid Arthritis in Sustained Clinical Remission for Decades
por: Tanemoto, Masanobu, et al.
Publicado: (2019)

Emollient treatment of atopic dermatitis: latest evidence and clinical considerations
por: Hon, Kam Lun, et al.
Publicado: (2018)

Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity
por: Huizinga, Tom W. J., et al.
Publicado: (2020)

Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission
por: Curtis, Jeffrey R., et al.
Publicado: (2021)

Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?
por: Nagy, György, et al.
Publicado: (2015)

Remission in Rheumatoid Arthritis
por: Shammas, Rania M., et al.
Publicado: (2010)

Long-term fracture risk in rheumatoid arthritis: impact of early sustained DAS28-remission and restored function, progressive erosive disease, body mass index, autoantibody positivity and glucocorticoids. A cohort study over 10 years
por: Ajeganova, Sofia, et al.
Publicado: (2023)

Physical function continues to improve when clinical remission is sustained in rheumatoid arthritis patients
por: Radner, Helga, et al.
Publicado: (2015)

Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis
por: Accortt, Neil A., et al.
Publicado: (2018)

Erosion-free rheumatoid arthritis: clinical and conceptional implications—a BARFOT study
por: Svensson, Björn, et al.
Publicado: (2022)

Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria
por: Svensson, Björn, et al.
Publicado: (2013)

Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations
por: In, Gino K., et al.
Publicado: (2017)

Aspects of early arthritis. Definition of disease states in early arthritis: remission versus minimal disease activity
por: van der Helm-van Mil, Annette HM, et al.
Publicado: (2006)

The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
por: Tanaka, Yoshiya, et al.
Publicado: (2019)

Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis
por: Emery, Paul, et al.
Publicado: (2023)

Anti-citrullinated protein antibodies are associated with osteopenia but not with pain at diagnosis of rheumatoid arthritis: data from the BARFOT cohort
por: Hafström, Ingiäld, et al.
Publicado: (2019)

Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients
por: Burkard, Theresa, et al.
Publicado: (2021)

Value of Remission in Patients with Rheumatoid Arthritis: A Targeted Review
por: Ostor, Andrew J., et al.
Publicado: (2021)

Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis
por: Emery, Paul, et al.
Publicado: (2013)

Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial
por: Ajeganova, Sofia, et al.
Publicado: (2014)

Misdiagnosis of Rheumatoid Arthritis in a Long-Term Cohort of Early Arthritis Based on the ACR-1987 Classification Criteria
por: Leu Agelii, Monica, et al.
Publicado: (2022)

Ultrasonographic findings of rheumatoid arthritis patients who are in clinical remission
por: Karimzadeh, Hadi, et al.
Publicado: (2018)

Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events
por: Ajeganova, Sofia, et al.
Publicado: (2021)

Genetics of rheumatoid arthritis: what have we learned?
por: Bax, Marieke, et al.
Publicado: (2011)

Validity of Remission Criteria in Rheumatoid Arthritis Compared to Ultrasound-Defined Remission
por: Ben Abdelghani, Kawther, et al.
Publicado: (2022)

Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets
por: van der Helm-van Mil, Annette HM, et al.
Publicado: (2008)

A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis
por: Ma, M. H. Y., et al.
Publicado: (2020)

The Economic Benefit of Remission for Patients with Rheumatoid Arthritis
por: Curtis, Jeffrey R., et al.
Publicado: (2022)

The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study
por: Emery, Paul, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_juclpgedkiamn3l9asuudde0or